4T1	Murine triple-negative breast cancer (TNBC) cells (Mimics human breast cancer stage IV)
AEs	Adverse events
CTCAE	Common Terminology Criteria for Adverse Events V 3.0
CV	Coriolus versicolor
DCFH-DA	2′,7′-dichlorodihydrofluorescein diacetate staining
DLT	Dose-limiting toxicity
ELISA	Enzyme-Linked Immunosorbent Assay
HBL-100	Human breast tumor cell line
HT	Holotomographic microscopy
LDH	Lactate dehydrogenase, cell in vitro viability assay
LPS	Lipopolysaccharide
MCF-7	Human breast adenocarcinoma cell line with positive estrogen and progesterone receptors
MDA-MB-231	Adenocarcinoma, highly aggressive, invasive and poorly differentiated triple-negative breast cancer (TNBC) cell line
MLKL	Mixed lineage kinase domain-like protein
MTT	(3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide) cell in vitro viability assay
NCI	National Cancer Institute
Nec-1	Specific inhibitor necrostatin-1
NK	Natural killer
PBPs	Protein-bound polysaccharides
qRT-PCR	Quantitative Reverse Transcription Polymerase Chain Reaction
RIPK1	Receptor-interacting protein1 kinase
RIPK3	Receptor-interacting protein 3 kinase
ROS	Reactive Oxygen Species
T47D	Ductal carcinoma, a cell line derived from the pleural effusion of infiltrating ductal breast cancer
TLR 4	Toll-like receptor
TPP	Three-phase partitioning
WB	Western blot analysis
WST-1	Water-soluble tetrazolium salt, in vitro viability and proliferation assay